Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System

por Fusaroli, Michele, Raschi, Emanuel, Giunchi, Valentina, Menchetti, Marco, Rimondini Giorgini, Roberto, De Ponti, Fabrizio, Poluzzi, Elisabetta
Publicado 2022

Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors

por Sisi, Monia, Vitale, Giovanni, Fusaroli, Michele, Riefolo, Mattia, Giunchi, Valentina, D’Errico, Antonietta, Ardizzoni, Andrea, Raschi, Emanuel, Gelsomino, Francesco
Publicado 2023

Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People

por Lunghi, Carlotta, Trevisan, Caterina, Fusaroli, Michele, Giunchi, Valentina, Raschi, Emanuel, Sangiorgi, Elisa, Domenicali, Marco, Volpato, Stefano, De Ponti, Fabrizio, Poluzzi, Elisabetta
Publicado 2022

Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System

por Fusaroli, Michele, Pelletti, Guido, Giunchi, Valentina, Pugliese, Chiara, Bartolucci, Mattia, Necibi, Elena Narmine, Raschi, Emanuel, De Ponti, Fabrizio, Pelotti, Susi, Poluzzi, Elisabetta
Publicado 2023

Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System

por Raschi, Emanuel, Fusaroli, Michele, Giunchi, Valentina, Repaci, Andrea, Pelusi, Carla, Mollica, Veronica, Massari, Francesco, Ardizzoni, Andrea, Poluzzi, Elisabetta, Pagotto, Uberto, Di Dalmazi, Guido
Publicado 2022